Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2

被引:171
作者
Lee, H
Trainer, AH
Friedman, LS
Thistlethwaite, FC
Evans, MJ
Ponder, BAJ
Venkitaraman, AR
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
[2] Cambridge Inst Med Res, Dept Oncol, Cambridge CB2 2XY, England
[3] Wellcome CRC, Inst Canc & Dev Biol, Cambridge CB2 1TR, England
基金
英国惠康基金;
关键词
D O I
10.1016/S1097-2765(00)80182-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The murine Brca2 gene encodes a nuclear protein implicated in DNA repair. Brca2 behaves as a tumor suppressor, but paradoxically, its truncation causes proliferative arrest and spontaneous chromosomal damage. Here, we report that inactivation of cell cycle checkpoints responsive to mitotic spindle disruption, by mutant forms of p53 or Bub1, relieves growth arrest and initiates neoplastic transformation in primary cells homozygous for truncated Brca2. Tumors from Brca2-deficient animals exhibit dysfunction of the spindle assembly checkpoint, accompanied by mutations in p53, Bub1, and Mad3L. The chromosomal aberrations precipitated by Brca2 truncation can be suppressed by mutant forms of Bub1 and p53. Thus, inactivating mutations in mitotic checkpoint genes likely cooperate with BRCA2 deficiency in the pathogenesis of inherited breast cancer, with important implications for treatment.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
[1]   Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro [J].
Baumann, P ;
Benson, FE ;
West, SC .
CELL, 1996, 87 (04) :757-766
[2]  
Bertwistle D, 1997, CANCER RES, V57, P5485
[3]   Dominant-negative p53 mutations selected in yeast hit cancer hot spots [J].
Brachmann, RK ;
Vidal, M ;
Boeke, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4091-4095
[4]   Double indemnity: p53, BRCA and cancer [J].
Brugarolas, J ;
Jacks, T .
NATURE MEDICINE, 1997, 3 (07) :721-722
[5]   Mutations of mitotic checkpoint genes in human cancers [J].
Cahill, DP ;
Lengauer, C ;
Yu, J ;
Riggins, GJ ;
Willson, JKV ;
Markowitz, SD ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1998, 392 (6673) :300-303
[6]   MICROINJECTION OF MITOTIC CELLS WITH THE 3F3/2 ANTI-PHOSPHOEPITOPE ANTIBODY DELAYS THE ONSET OF ANAPHASE [J].
CAMPBELL, MS ;
GORBSKY, GJ .
JOURNAL OF CELL BIOLOGY, 1995, 129 (05) :1195-1204
[7]   In vitro analysis of the dominant negative effect of p53 mutants [J].
Chène, P .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 281 (02) :205-209
[8]   CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[9]  
COLLINS N, 1995, ONCOGENE, V10, P1673
[10]   Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation [J].
Connor, F ;
Bertwistle, D ;
Mee, PJ ;
Ross, GM ;
Swift, S ;
Grigorieva, E ;
Tybulewicz, VLJ ;
Ashworth, A .
NATURE GENETICS, 1997, 17 (04) :423-430